METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours

METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ecancermedicalscience 2022-07, Vol.16
Hauptverfasser: Glasberg, João, Talans, Aley, Giollo, Thomás Rivelli, Recchimuzzi, Débora Zachello, Neto, João Evangelista Bezerra, Lopez, Rossana Veronica Mendonza, Hoff, Paulo Marcelo Gehm, Riechelmann, Rachel P
Format: Artikel
Sprache:eng
Schlagworte:
Erratum
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Ecancermedicalscience
container_volume 16
creator Glasberg, João
Talans, Aley
Giollo, Thomás Rivelli
Recchimuzzi, Débora Zachello
Neto, João Evangelista Bezerra
Lopez, Rossana Veronica Mendonza
Hoff, Paulo Marcelo Gehm
Riechelmann, Rachel P
description
doi_str_mv 10.3332/ecancer.2022.1421
format Article
fullrecord <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9458264</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_9458264</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_94582643</originalsourceid><addsrcrecordid>eNqljM1KxDAUhYMgzvjzAO7uC7QmadNpXbiRirMYV92Ha3tjI21SktTBt7cLN66FAwe-w3cYuxc8L4pCPlCPrqeQSy5lLkopLtheHFSZVRVXO3Yd4yfnlWikumK7ohKqbg71nuGp7d7a7hEQlhEjwfEIKVicwBuYKRkfZutgy4LJkksRzjaNcKZpygZrDIUNWkw0gKM1eHKD74N1BGmd_RriLbs0OEW6--0b9vTSds-v2bK-zzT0mx5w0kuwM4Zv7dHqv4uzo_7wX7opVS2rsvj3wQ93m2P2</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Glasberg, João ; Talans, Aley ; Giollo, Thomás Rivelli ; Recchimuzzi, Débora Zachello ; Neto, João Evangelista Bezerra ; Lopez, Rossana Veronica Mendonza ; Hoff, Paulo Marcelo Gehm ; Riechelmann, Rachel P</creator><creatorcontrib>Glasberg, João ; Talans, Aley ; Giollo, Thomás Rivelli ; Recchimuzzi, Débora Zachello ; Neto, João Evangelista Bezerra ; Lopez, Rossana Veronica Mendonza ; Hoff, Paulo Marcelo Gehm ; Riechelmann, Rachel P</creatorcontrib><identifier>EISSN: 1754-6605</identifier><identifier>DOI: 10.3332/ecancer.2022.1421</identifier><identifier>PMID: 36158978</identifier><language>eng</language><publisher>Cancer Intelligence</publisher><subject>Erratum</subject><ispartof>Ecancermedicalscience, 2022-07, Vol.16</ispartof><rights>the authors; licensee cancermedicalscience. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458264/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458264/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,729,782,786,866,887,27931,27932,53798,53800</link.rule.ids></links><search><creatorcontrib>Glasberg, João</creatorcontrib><creatorcontrib>Talans, Aley</creatorcontrib><creatorcontrib>Giollo, Thomás Rivelli</creatorcontrib><creatorcontrib>Recchimuzzi, Débora Zachello</creatorcontrib><creatorcontrib>Neto, João Evangelista Bezerra</creatorcontrib><creatorcontrib>Lopez, Rossana Veronica Mendonza</creatorcontrib><creatorcontrib>Hoff, Paulo Marcelo Gehm</creatorcontrib><creatorcontrib>Riechelmann, Rachel P</creatorcontrib><title>METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours</title><title>Ecancermedicalscience</title><subject>Erratum</subject><issn>1754-6605</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqljM1KxDAUhYMgzvjzAO7uC7QmadNpXbiRirMYV92Ha3tjI21SktTBt7cLN66FAwe-w3cYuxc8L4pCPlCPrqeQSy5lLkopLtheHFSZVRVXO3Yd4yfnlWikumK7ohKqbg71nuGp7d7a7hEQlhEjwfEIKVicwBuYKRkfZutgy4LJkksRzjaNcKZpygZrDIUNWkw0gKM1eHKD74N1BGmd_RriLbs0OEW6--0b9vTSds-v2bK-zzT0mx5w0kuwM4Zv7dHqv4uzo_7wX7opVS2rsvj3wQ93m2P2</recordid><startdate>20220704</startdate><enddate>20220704</enddate><creator>Glasberg, João</creator><creator>Talans, Aley</creator><creator>Giollo, Thomás Rivelli</creator><creator>Recchimuzzi, Débora Zachello</creator><creator>Neto, João Evangelista Bezerra</creator><creator>Lopez, Rossana Veronica Mendonza</creator><creator>Hoff, Paulo Marcelo Gehm</creator><creator>Riechelmann, Rachel P</creator><general>Cancer Intelligence</general><scope>5PM</scope></search><sort><creationdate>20220704</creationdate><title>METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours</title><author>Glasberg, João ; Talans, Aley ; Giollo, Thomás Rivelli ; Recchimuzzi, Débora Zachello ; Neto, João Evangelista Bezerra ; Lopez, Rossana Veronica Mendonza ; Hoff, Paulo Marcelo Gehm ; Riechelmann, Rachel P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_94582643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Erratum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Glasberg, João</creatorcontrib><creatorcontrib>Talans, Aley</creatorcontrib><creatorcontrib>Giollo, Thomás Rivelli</creatorcontrib><creatorcontrib>Recchimuzzi, Débora Zachello</creatorcontrib><creatorcontrib>Neto, João Evangelista Bezerra</creatorcontrib><creatorcontrib>Lopez, Rossana Veronica Mendonza</creatorcontrib><creatorcontrib>Hoff, Paulo Marcelo Gehm</creatorcontrib><creatorcontrib>Riechelmann, Rachel P</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Ecancermedicalscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Glasberg, João</au><au>Talans, Aley</au><au>Giollo, Thomás Rivelli</au><au>Recchimuzzi, Débora Zachello</au><au>Neto, João Evangelista Bezerra</au><au>Lopez, Rossana Veronica Mendonza</au><au>Hoff, Paulo Marcelo Gehm</au><au>Riechelmann, Rachel P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours</atitle><jtitle>Ecancermedicalscience</jtitle><date>2022-07-04</date><risdate>2022</risdate><volume>16</volume><eissn>1754-6605</eissn><pub>Cancer Intelligence</pub><pmid>36158978</pmid><doi>10.3332/ecancer.2022.1421</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 1754-6605
ispartof Ecancermedicalscience, 2022-07, Vol.16
issn 1754-6605
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9458264
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; PubMed Central
subjects Erratum
title METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T18%3A09%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=METNET:%20a%20phase%20II%20trial%20of%20metformin%20in%20patients%20with%20well-differentiated%20neuroendocrine%20tumours&rft.jtitle=Ecancermedicalscience&rft.au=Glasberg,%20Jo%C3%A3o&rft.date=2022-07-04&rft.volume=16&rft.eissn=1754-6605&rft_id=info:doi/10.3332/ecancer.2022.1421&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_9458264%3C/pubmedcentral%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/36158978&rfr_iscdi=true